amantadine has been researched along with Cardiac Hypertrophy in 1 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nair, KG | 1 |
| Umali, T | 1 |
| Potts, J | 1 |
1 other study available for amantadine and Cardiac Hypertrophy
| Article | Year |
|---|---|
Ribonucleic acid (RNA) polymerase and adenyl cyclase in cardiac hypertrophy and cardiomyopathy.
Topics: Adenylyl Cyclases; Amantadine; Animals; Aorta; Cardiomegaly; Cricetinae; Disease Models, Animal; DNA | 1973 |